💊 Empagliflozin
29 impuritiess available on this parent drug
Empagliflozin, IUPAC name 1-(4-chlorophenyl)-3-((3-(4-chlorophenyl)-5,5-dimethyl-4-oxo-1-pyrrolidinyl)methyl)-1H-pyrazole-4-carboxylic acid, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Its molecular formula is C19H18Cl2N4O3 (molecular weight: 413.27 g/mol). Structurally, it features a pyrazole ring fused to a pyrrolidinone core with chlorophenyl substituents. Therapeutically, it is used for managing type 2 diabetes mellitus by reducing renal glucose reabsorption. It is a white to off-white solid with moderate water solubility (pKa ~4.5) and high metabolic stability. Mechanistically, it selectively inhibits SGLT2 in renal proximal tubules, promoting glucosuria and lowering blood glucose levels.
On Request
ABC00618PWCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00602QWCAS864070-43-9
MFC23H27ClO7
MW450.9
PurityN/A
On Request
ABC00613GNCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00612ROCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00616ZECAS1044664-24-5
MFC26H23F2NO4
MW451.5
PurityN/A
On Request
ABC00617ZXCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00615SMCAS864070-44-0
MFC23H27ClO7
MW450.9
PurityN/A
On Request
ABC07304FWCAS1279691-35-8
MFC24H29ClO8
MW480.9
PurityN/A
On Request
ABC07302JMCASN/A
MFC23H29ClO8
MW468.9
PurityN/A
On Request
ABC07303VPCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00601XECAS1620758-33-9
MFC23H27ClO7
MW450.9
PurityN/A
On Request
ABC07305PVCASN/A
MFC23H27ClO7
MW450.9
PurityN/A
On Request
ABC07306ZXCASN/A
MFC18H17ClO4
MW332.8
PurityN/A
On Request
ABC07307PACAS915095-89-5
MFC17H16BrClO2
MW367.7
PurityN/A
On Request
ABC00605TSCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC00606CRCASN/A
MFN/A
MWN/A
PurityN/A
On Request
ABC07309FLCASN/A
MFC23H27O8Cl
MW466.14
PurityN/A
On Request
ABC00614FLCASN/A
MFC17H17ClO3
MW304.8
PurityN/A
On Request
ABC00611TKCAS1800196-46-6
MFC17H16ClIO3
MW430.7
PurityN/A
On Request
ABC00598KUCAS1360568-68-8
MFC13H8BrClO2
MW311.56
PurityN/A
